Pharmaceutical manufacturers of Florfenicol

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

Established in 1993, SUANFARMA is a business-to-business partner in the field of life sciences specializing in the formulation, manufacture, and marketing of components for the pharmaceutical, veterinary, and nutraceutical sectors. In SUANFARMA, we provide our CDMO capabilities for fermentation and chemical synthesis projects, delivering a comprehensive service with a proven track record, facilitating success in the formulation, expansion, production, and marketing of an API, whether it is innovative or generic

We are the primary manufacturer of Avermectin worldwide and the leading producer of Ivermectin in Asia, with an annual production that constitutes half of the total in China. Additionally, we hold the top position as the producer for Tiamulin, Eprinomectin, and Emamectin Benzoate in China.

Minsheng Group Shaoxing Pharmaceutical Co., Ltd.（herein after called Minsheng), located in Shaoxing city, China. With its extensive expertise and advanced facilities, Minsheng specializes in manufacturing APIs. Minsheng is the subsidiary of Hangzhou Minsheng Pharmaceutical Holding Group Co.,Ltd. which has nearly 100 years history. Covering a total area of 235,000M2, Minsheng has nearly 500 employees. More than 30% of these professionals are specialized technical personnel. Minsheng primarily manufactures over 30 types of APIs, with approximately 50% of the output being exported. Nine products have obtained US FDA approval , two products have acquired EU CEP, one product has received recognition from Japan PMDA, and one product has listed in WHO PQ. Minsheng possesses extensive experience in collaborating with big pharma. Companies. Minsheng pays much attention on regulatory compliance including but not limited to GMP and EHS. Minsheng also focus on R&D new projects, fully support all innovation ideas & execution. Minsheng has a new plant site in a specialized Chemical Park, Shangyu city. Minsheng now is embracing new projects and larger development.

Yangzhou Liberty Pharmaceutical Co Ltd operates as an API manufacturer and a collaborative enterprise rooted in Yangzhou Pharmaceutical Co Ltd. In 2013, our firm took over Datong Tongxing Antibiotic Co Ltd in Shanxi Province, solidifying our position as the holding company. In addition to our current operations, we are dedicated to the development and manufacture of alternative fermentation raw materials. Leveraging an advanced quality control system, several of our products have successfully navigated rigorous assessments, including inspection by the US FDA, as well as securing COS, EU-GMP, and GMP certifications. Anhui Liberty Pharmaceutical Co Ltd and Datong Tongxing Antibiotic Co Ltd are also integral parts of our enterprise.